Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Reitz

Showing results (381-390 of 400) with videos related to

Pageof 40
Sort By:
Annals of Surgery|October 1, 1981
Long-term survival and function after cardiac transplantationV A Gaudiani, E B Stinson, E Alderman, et al.
Transplantation|December 27, 2005
Combined use of the JAK3 inhibitor CP-690,550 with mycophenolate mofetil to prevent kidney allograft rejection in nonhuman primatesDominic C Borie, Michael J Larson, Mona G Flores, et al.
The Journal of Thoracic and Cardiovascular Surgery|July 1, 1980
Hemodynamic and clinical comparison of the Hancock modified orifice and standard orifice bioprostheses in the aortic positionS J Rossiter, D C Miller, E B Stinson, et al.
The Annals of Thoracic Surgery|August 1, 1996
Port-access coronary artery bypass with cardioplegic arrest: acute and chronic canine studiesJ H Stevens, T A Burdon, L C Siegel, et al.
Urologie (Heidelberg, Germany)|May 16, 2024
[Intravesical oxybutynin treatment for neurogenic detrusor overactivity : Efficacy and safety data from clinical practice with the first intravesical oxybutynin treatment authorized in Germany]O Schindler, H Ho, Q Leidl, et al.
Freshwater Biology|December 31, 2021
Toxic benthic freshwater cyanobacterial proliferations: Challenges and solutions for enhancing knowledge and improving monitoring and mitigationSusanna A Wood, Laura Kelly, Keith Bouma-Gregson, et al.
Bioorganic & Medicinal Chemistry Letters|December 23, 2008
2-(6-Phenyl-1H-indazol-3-yl)-1H-benzo[d]imidazoles: design and synthesis of a potent and isoform selective PKC-zeta inhibitorJohn I Trujillo, James R Kiefer, Wei Huang, et al.
The Journal of Biological Chemistry|May 24, 2000
Characterization of the recombinant IKK1/IKK2 heterodimer. Mechanisms regulating kinase activityQ K Huynh, H Boddupalli, S A Rouw, et al.
Environmental Science & Technology|September 29, 2018
Terrestrial Origin for Abundant Riverine Nanoscale Ice-Nucleating ParticlesKathryn A Knackstedt, Bruce F Moffett, Susan Hartmann, et al.
Bioorganic & Medicinal Chemistry Letters|February 9, 2010
Structure-based drug design enables conversion of a DFG-in binding CSF-1R kinase inhibitor to a DFG-out binding modeMarvin J Meyers, Matthew Pelc, Satwik Kamtekar, et al.
Pageof 40

Showing results (381-390 of 400) with videos related to

Sort By:
Pageof 40
Annals of Surgery|October 1, 1981
Long-term survival and function after cardiac transplantationV A Gaudiani, E B Stinson, E Alderman, et al.
Transplantation|December 27, 2005
Combined use of the JAK3 inhibitor CP-690,550 with mycophenolate mofetil to prevent kidney allograft rejection in nonhuman primatesDominic C Borie, Michael J Larson, Mona G Flores, et al.
The Journal of Thoracic and Cardiovascular Surgery|July 1, 1980
Hemodynamic and clinical comparison of the Hancock modified orifice and standard orifice bioprostheses in the aortic positionS J Rossiter, D C Miller, E B Stinson, et al.
The Annals of Thoracic Surgery|August 1, 1996
Port-access coronary artery bypass with cardioplegic arrest: acute and chronic canine studiesJ H Stevens, T A Burdon, L C Siegel, et al.
Urologie (Heidelberg, Germany)|May 16, 2024
[Intravesical oxybutynin treatment for neurogenic detrusor overactivity : Efficacy and safety data from clinical practice with the first intravesical oxybutynin treatment authorized in Germany]O Schindler, H Ho, Q Leidl, et al.
Freshwater Biology|December 31, 2021
Toxic benthic freshwater cyanobacterial proliferations: Challenges and solutions for enhancing knowledge and improving monitoring and mitigationSusanna A Wood, Laura Kelly, Keith Bouma-Gregson, et al.
Bioorganic & Medicinal Chemistry Letters|December 23, 2008
2-(6-Phenyl-1H-indazol-3-yl)-1H-benzo[d]imidazoles: design and synthesis of a potent and isoform selective PKC-zeta inhibitorJohn I Trujillo, James R Kiefer, Wei Huang, et al.
The Journal of Biological Chemistry|May 24, 2000
Characterization of the recombinant IKK1/IKK2 heterodimer. Mechanisms regulating kinase activityQ K Huynh, H Boddupalli, S A Rouw, et al.
Environmental Science & Technology|September 29, 2018
Terrestrial Origin for Abundant Riverine Nanoscale Ice-Nucleating ParticlesKathryn A Knackstedt, Bruce F Moffett, Susan Hartmann, et al.
Bioorganic & Medicinal Chemistry Letters|February 9, 2010
Structure-based drug design enables conversion of a DFG-in binding CSF-1R kinase inhibitor to a DFG-out binding modeMarvin J Meyers, Matthew Pelc, Satwik Kamtekar, et al.
Pageof 40